Guangzhou Patronus Biotech Co., Ltd.

This study is testing a new shingles vaccine called LYB004 to see how well it triggers an immune response and how safe it is. It will involve 840 adults in China aged 40 and older, who will receive different versions of the vaccine or a placebo. The main goal is to measure the bo…

This study is testing a new vaccine called LYB005 to prevent serious illness from Respiratory Syncytial Virus (RSV) in adults aged 60 and older. Researchers will give 700 participants either one of six different vaccine formulas or a placebo shot to compare how well their immune …